Sonoma Pharmaceuticals (SNOA) Shares Outstanding (Entity) (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 834.66 Mn |
| 10 | Sonoma Pharmaceuticals | 5.13 Mn | -203,589.85 | 2.58 Mn | 3.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.85 Mn |
| Mar 31, 2026 | 1.80 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.64 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 950,220.00 |
| Mar 31, 2024 | 454,500.00 |
| Dec 31, 2023 | 545,450.00 |
| Sep 30, 2023 | 258.00 |
| Jun 30, 2023 | 247.00 |
| Mar 31, 2023 | 170.00 |
| Dec 31, 2022 | 155.00 |
| Sep 30, 2022 | 155.00 |
| Jun 30, 2022 | 155,047.00 |
| Mar 31, 2022 | 155,047.00 |
| Dec 31, 2021 | 154.00 |
| Sep 30, 2021 | 117,200.00 |